Editorial: Innovative immunotherapy strategies for enhanced treatment of Hodgkin and non-Hodgkin lymphomas

Front Immunol. 2025 Jun 20:16:1642505. doi: 10.3389/fimmu.2025.1642505. eCollection 2025.

Authors

Michael J Robertson¹, Eric Vivier², Penny Fang³

Affiliations

¹ Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN, United States.
² Centre d'Immunologie de Marseille-Luminy, Marseille, France.
³ Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

No abstract available

Keywords: CAR (chimeric antigen receptor) T-cell therapy; immune checkpoint inhibitors; immunotherapy; lymphoma; monoclonal Abs.

Publication types

Editorial